Table 2.
Impedimetric analysis of serum samples from PCa patients (highlighted in light red) and healthy individuals (highlighted in light green).
| A | B | C | D | E | F | G | H | I | |
|---|---|---|---|---|---|---|---|---|---|
| Patient # | Biosensor Rct (kΩ) | + serum Rct (kΩ) | + MAA Rct (kΩ) | + serum Rel. (%) a | + MAA Rel. (%) b | + serum Aver. (%) ± SD | + MAA Aver. (%) ± SD | MAA/serum | MAA/serum Aver. (%) ± SD |
| 1 | 7.0 | 16.0 | 27.4 | 128 | 71.3 | 120 ± 37 | 43.4 ± 24.1 | 0.554 | 0.374 ± 0.183 |
| 1 | 18.5 | 33.3 | 43.4 | 80 | 30.3 | 0.379 | |||
| 1 | 21.1 | 53.2 | 68.5 | 152 | 28.8 | 0.189 | |||
| 2 | 7.5 | 22.4 | 33.3 | 199 | 48.7 | 156 ± 48 | 54.2 ± 6.0 | 0.245 | 0.374 ± 0.135 |
| 2 | 8.4 | 17.1 | 26.2 | 103 | 53.2 | 0.514 | |||
| 2 | 5.8 | 15.5 | 24.9 | 167 | 60.6 | 0.363 | |||
| 3 | 12.3 | 28.8 | 54.6 | 134 | 89.6 | 162 ± 36 | 98.5 ± 38.7 | 0.668 | 0.601 ± 0.142 |
| 3 | 19.1 | 57.7 | 139.0 | 202 | 140.9 | 0.697 | |||
| 3 | 18.9 | 47.0 | 77.6 | 149 | 65.1 | 0.438 | |||
| 4 | 22.2 | 32.1 | 32.2 | 45 | 0.312 | 62 ± 32 | 0.543 ± 0.223 | 0.007 | 0.011 ± 0.006 |
| 4 | 37.1 | 52.9 | 53.3 | 43 | 0.756 | 0.018 | |||
| 4 | 26.9 | 53.5 | 53.8 | 99 | 0.561 | 0.006 | |||
| 5 | 6.3 | 9.4 | 10.4 | 49 | 10.6 | 68 ± 27 | 8.45 ± 6.87 | 0.216 | 0.159 ± 0.133 |
| 5 | 17.1 | 26.5 | 30.2 | 55 | 14.0 | 0.254 | |||
| 5 | 26.9 | 53.5 | 53.9 | 99 | 0.75 | 0.008 | |||
| 6 | 22.7 | 41.6 | 42.6 | 83 | 2.40 | 69 ± 18 | 5.64 ± 3.57 | 0.029 | 0.086 ± 0.051 |
| 6 | 19.4 | 33.8 | 37.0 | 74 | 9.47 | 0.128 | |||
| 6 | 29.3 | 43.7 | 45.9 | 49 | 5.03 | 0.102 |
Legend: a = ((B-A)/A*100)-100; b = ((C-B)/B*100)-100; samples 1-3 were from PCa patients and samples 4-6 were from healthy individuals; Aver. = an average value; SD = standard deviation; MAA = after incubation with Maackia amurensis agglutinin. All six samples were measured at least in triplicate.